Expression of the membrane-cytoskeletal linker Ezrin in salivary gland adenoid cystic carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 112, Issue 1, 2011, Pages 96-104

  Wang, You Yuan ^a   Chen, Wei Liang ^a   Huang, Zhi Quan ^a   Yang, Zhao Hui ^a   Zhang, Bin ^a   Wang, Jian Guang ^a   Li, Hai Gang ^a   Li, Jin Song ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V6 ANTIGEN; CYTOSKELETON PROTEIN; EZRIN; HERMES ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; NOS2 PROTEIN, HUMAN; PLAKIN;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER INVASION; CANCER STAGING; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SALIVARY GLAND TUMOR; SURVIVAL RATE; TUMOR CELL LINE; TUMOR RECURRENCE;

ANTIGENS, CD44; CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NITRIC OXIDE SYNTHASE TYPE II; PLAKINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; SURVIVAL RATE;

EID: 79958768668     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2011.02.018     Document Type: Article

References (39)

1. Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6,982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg 2010;39:235-42.
2. van der Wal JE, Becking AG, Snow GB, van der Waal I. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck 2002;24:779-83. (Pubitemid 34857305)
3. Sung MW, Kim KH, Kim JW, Min YG, Seong WJ, Roh JL, et al. Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2003;129:1193-7. (Pubitemid 37433155)
4. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, et al. The membrane cytoskeleton linker Ezrin is necessary for osteosarcoma metastasis. Nat Med 2004;10:182-6. (Pubitemid 38524889)
5. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004;10:175-81. (Pubitemid 38524888)
6. Niggli V, Rossy J. Ezrin/Radixin/Moesin: versatile controllers of signaling molecules and of the cortical cytoskeleton. Int J Biochem Cell Biol 2008;40:344-9. (Pubitemid 351241219)
7. Fehon RG, McClatchey AI, Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol 2010;11:276-87.
8. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med 2004;10:201-4. (Pubitemid 38581790)
9. Martin TA, Harrison G, Mansel RE, Jiang WG. The role of the CD44/Ezrin complex in cancer metastasis. Crit Rev Oncol/Hematol 2003;46:165-86. (Pubitemid 36452345)
10. Mielgo A, Brondani V, Landmann L, Glaser-Ruhm A, Erb P, Stupack D, et al. The CD44 standard/Ezrin complex regulates Fas-mediated apoptosis in Jurkat cells. Apoptosis 2007;12: 2051-61. (Pubitemid 47498223)
11. Kuo WC, Yang KT, Hsieh SL, Lai MZ. Ezrin is a negative regulator of death receptor-induced apoptosis. Oncogene 2010; 29:1374-83.
12. Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M. The membrane cytoskeletal crosslinker Ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 2005;7: R365-73.
13. Xie JJ, Xu LY, Xie YM, Zhang HH, Cai WJ, Zhou F, et al. Roles of Ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer 2009;124:2549-58.
14. Chuan YC, Iglesias-Gato D, Fernandez-Perez L, Cedazo-Minguez A, Pang ST, Norstedt G, et al. Ezrin mediates c-Myc actions in prostate cancer cell invasion. Oncogene 2010;29:1531-42.
15. Weng WH, Ahlén J, Aström K, Lui WO, Larsson C. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005;11: 6198-204. (Pubitemid 41262948)
16. Kanke M, Fujii M, Kameyama K, Kanzaki J, Tokumaru Y, Imanishi Y, et al. Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2000;126:1217-23.
17. Ziche M, Morbidelli L. Molecular regulation of tumour angiogenesis by nitric oxide. Eur Cytokine Netw 2009;20:164-70.
18. Connelly ST, Macabeo-Ong M, Dekker N, Jordan RC, Schmidt BL. Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol 2005;41:261-7. (Pubitemid 40311754)
19. Glynne PA, Darling KE, Picot J, Evans TJ. Epithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output. J Biol Chem 2002;277: 33132-8. (Pubitemid 34984830)
20. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311-22. (Pubitemid 30054364)
21. Cordes C, Münzel AK, Rudolph P, Hoffmann M, Leuschner I, Gottschlich S. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma. Anticancer Res 2009;29:1459-65.
22. Wang YY, Chen WL, Yang ZH, Huang ZQ, Li JS, Pan CB. Effects of Ezrin gene on the proliferation and invasion activity of human salivary gland adenoid cystic carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi 2009;44:203-7.
23. Wang YY, Chen WL, Zhang WX, Bai ZB, Huang ZQ, Li JS. Ezrin and inducible nitric oxide synthase in malignant proliferation of salivary gland pleomorphic adenoma. Chin J Cancer 2009;28:1072-6.
24. Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumors: pathology and genetics of head and neck tumours. Lyon: IARC; 2005.
25. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 6th ed. New York: Wiley and Sons; 2002.
26. Guan X, Qiu W, He R, Zhou XJ. Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Int J Oral Maxillofac Surg 1997;26:116-9. (Pubitemid 127357228)
27. Chen WL, Yang L, Zeng SG, Wang YJ. Effect of using RNA interference to alter iNOS gene expression on the proliferation of tongue squamous cell carcinoma cell line Tca8113. Br J Oral Maxillofac Surg 2008;46:435-8.
28. Zhang J, Peng B, Chen X. Expressions of nuclear factor kappa B, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 2005;11:7334-43. (Pubitemid 41507692)
29. Brambilla D, Fais S. The Janus-faced role of Ezrin in "linking" cells to either normal or metastatic phenotype. Int J Cancer 2009;125:2239-45.
30. Zhou R, Cao X, Watson C, Miao Y, Guo Z, Forte JG, et al. Characterization of protein kinase A-mediated phosphorylation of Ezrin in gastric parietal cell activation. J Biol Chem 2003; 278:35651-9. (Pubitemid 37102339)
31. Fonseca I, Moura-Nunes JF, Soares J. Expression of CD44 isoforms in normal salivary gland tissue: an immunohistochemical and ultrastructural study. Histochem Cell Biol 2000; 114:483-8. (Pubitemid 32039599)
32. Yeh CN, Pang ST, Chen TW, Wu RC, Weng WH, Chen MF. Expression of Ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma. BMC Cancer 2009;9:233.
33. Di Cristofano C, Leopizzi M, Miraglia A, Sardella B, Moretti V, Alessandro-Ferrara, et al. Phosphorylated Ezrin is located in the nucleus of the osteosarcoma cell. Mod Pathol 2010;23:1012-20.
34. Ren L, Hong SH, Cassavaugh J, Osborne T, Chou AJ, Kim SY, et al. The actin-cytoskeleton linker protein Ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 2009; 28:792-802.
35. Wang G, Mao W, Zheng S. MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 2008;582:3663-8.
36. Thorne RF, Legg JW, Isacke CM. The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signaling events. J Cell Sci 2004;117:373-80. (Pubitemid 38181198)
37. Legg JW, Lewis CA, Parsons M, Ng T, Isacke CM. A novel PKC-regulated mechanism controls CD44 Ezrin association and directional cell motility. Nat Cell Biol 2002;4:399-407. (Pubitemid 34746157)
38. Youn JY, Wang T, Cai H. An Ezrin/Calpain/PI3K/AMPK/ eNOSs1179 signaling cascade mediating VEGF-dependent endothelial nitric oxide production. Circ Res 2009;104:50-9.
39. Nordgard S, Franzen G, Boysen M, Halvorsen TB. Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB-1 in paraffin sections. Laryngoscope 1997;107:531-6. (Pubitemid 27176065)